© ETQ, LLC All Rights Reserved.
700 District Ave
Burlington, MA 01803
FARMINGDALE, NY (09-10-12): EtQ is pleased to announce that they have been presented with the enterprise Quality and Regulatory Management System (eQRMS) Project Leadership Award from Celgene Corporation.
The Celgene eQRMS Project Team presented this award to EtQ in representation of the global reach and spirit of their EtQ deployment, which they consider to have been "cross-functional, international, and collaborative."
"EtQ is pleased to have the opportunity to work with the Celgene eQRMS Project Team and to assist them in meeting their eQRMS goals," stated Glenn McCarty, chief executive officer at EtQ. "This award is a symbol for EtQ on how focusing on customer needs, coupled with a spirit of collaboration and innovation can accomplish great things for all parties involved. It is an honor to have been presented this award and we are looking forward to continuing our collaboration with the eQMS Project Team. We are thrilled to have been with Celgene on their journey toward their first global, enterprise platform—it has truly been a pleasure."
EtQ is extremely grateful for the opportunity given by Celgene, and for the opportunity to work with such a dynamic and innovative organization. As EtQ moves toward the next milestone, they look forward to continuing this spirit of collaboration and innovation with Celgene for years to come.
Celgene Corporation is a global biopharmaceutical company committed to improving the lives of patients worldwide. Celgene seeks to deliver truly innovative and life-changing drugs for its patients. The company mission is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer.
Celebrating 20 Years of Excellence
Founded on March 4, 1992 by former lead auditors of Underwriters Laboratories, EtQ has always had a unique knowledge of quality and compliance processes, and strives to make overall quality operations and quality systems better for businesses. This year, EtQ celebrates 20 years of Excellence through Quality and continues to be the leading Quality, Compliance, and Environmental Health and Safety solution provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. EtQ uses best in class integrated modules and enterprise application integration to manage and measure quality and compliance processes and execute organizational change. EtQ's solution, Reliance, is an enterprise suite of modules designed to foster operational excellence in businesses with modules such as CAPA, Document Control, Risk Management, Nonconformances, Audits, Complaint Handling, Incidents, Sustainability, Job Safety Analysis, HACCP, Reporting and many more. EtQ has been providing compliance solutions to a variety of markets for 20 years.
EtQ is a trademark of EtQ Management Consultants, Inc. All other product names and company names are trademarks or registered trademarks of their respective owners.